BR9503775A - Compostos e composição farmacêutica útil como um agente analgésico antiinflamatório diurético ou neuroprotetor - Google Patents
Compostos e composição farmacêutica útil como um agente analgésico antiinflamatório diurético ou neuroprotetorInfo
- Publication number
- BR9503775A BR9503775A BR9503775A BR9503775A BR9503775A BR 9503775 A BR9503775 A BR 9503775A BR 9503775 A BR9503775 A BR 9503775A BR 9503775 A BR9503775 A BR 9503775A BR 9503775 A BR9503775 A BR 9503775A
- Authority
- BR
- Brazil
- Prior art keywords
- pct
- diuretic
- compounds
- neuroprotective
- unsubstituted
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/12—Oxygen or sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D207/33—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D207/335—Radicals substituted by nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Pyrrole Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/JP1994/001399 WO1996006078A1 (en) | 1994-08-24 | 1994-08-24 | N-(2-(pyrrolidinyl-1)-1-phenylethyl)acetamides as kappa receptor antagonists |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR9503775A true BR9503775A (pt) | 1996-04-16 |
Family
ID=14098616
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR9503775A BR9503775A (pt) | 1994-08-24 | 1995-08-23 | Compostos e composição farmacêutica útil como um agente analgésico antiinflamatório diurético ou neuroprotetor |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US5837720A (pt) |
| EP (1) | EP0777649B1 (pt) |
| JP (1) | JP2935899B2 (pt) |
| AT (1) | ATE182138T1 (pt) |
| AU (1) | AU2350695A (pt) |
| BR (1) | BR9503775A (pt) |
| CA (1) | CA2196885C (pt) |
| CO (1) | CO4410322A1 (pt) |
| DE (1) | DE69510802T2 (pt) |
| DK (1) | DK0777649T3 (pt) |
| ES (1) | ES2133767T3 (pt) |
| FI (1) | FI116056B (pt) |
| GR (1) | GR3031133T3 (pt) |
| IL (1) | IL114969A0 (pt) |
| MX (1) | MX9701367A (pt) |
| TR (1) | TR199501055A2 (pt) |
| WO (2) | WO1996006078A1 (pt) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6239154B1 (en) | 1996-03-08 | 2001-05-29 | Adolor Corporation | Kappa agonist compounds pharmaceutical formulations and method of prevention and treatment of pruritus therewith |
| US5763445A (en) | 1996-03-08 | 1998-06-09 | Adolor Corporation | Kappa agonist compounds pharmaceutical formulations and method of prevention and treatment of pruritus therewith |
| US6133307A (en) * | 1997-04-30 | 2000-10-17 | Warner-Lambert Company | Certain benzofuranyl-N-[pyrrolidin-1-YL]-N-methyl-acetamide derivatives useful as opioid agonists |
| BR9810706A (pt) * | 1997-07-14 | 2000-08-08 | Adolor Corp | Processo para a prevenção ou tratamento do prurido em um mamìfero em necessidade de tal prevenção ou tratamento |
| US5760023A (en) * | 1997-07-14 | 1998-06-02 | Adolor Corporation | Kappa agonist anti-pruritic pharmaceutical formulations and method of treating pruritus therewith |
| US6284769B1 (en) | 1999-12-03 | 2001-09-04 | The Board Of Trustees Of The University Of Illinois | Nonpeptide kappa opioid receptor antagonists |
| WO2014148574A1 (ja) * | 2013-03-22 | 2014-09-25 | 参天製薬株式会社 | Ｉｌ－２産生抑制 |
| JP6577943B2 (ja) | 2013-06-28 | 2019-09-18 | ネクター セラピューティクス | κオピオイド作動薬及びその使用 |
| WO2015114660A1 (en) * | 2014-01-24 | 2015-08-06 | Cadila Healtchare Limited | Novel heterobicyclic compounds as kappa opioid agonists |
| KR20180017013A (ko) | 2015-05-06 | 2018-02-20 | 더 리젠츠 오브 더 유니버시티 오브 캘리포니아 | K-Ras 조절제 |
| AU2018255413A1 (en) | 2017-04-20 | 2019-12-05 | Leidos Biomedical Research, Inc. | K-Ras modulators |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4034785A1 (de) * | 1990-11-02 | 1992-05-07 | Merck Patent Gmbh | 1-(2-arylethyl)-pyrrolidine |
| US5232978A (en) * | 1988-12-23 | 1993-08-03 | Merck Patent Gesellschaft Mit Beschrankter Haftung | 1-(2-arylethyl)-pyrrolidines |
| DE4215213A1 (de) * | 1992-05-09 | 1993-11-11 | Merck Patent Gmbh | Arylacetamide |
-
1994
- 1994-08-24 WO PCT/JP1994/001399 patent/WO1996006078A1/en unknown
-
1995
- 1995-05-18 CA CA002196885A patent/CA2196885C/en not_active Expired - Fee Related
- 1995-05-18 DK DK95917437T patent/DK0777649T3/da active
- 1995-05-18 DE DE69510802T patent/DE69510802T2/de not_active Expired - Fee Related
- 1995-05-18 WO PCT/IB1995/000374 patent/WO1996006077A1/en active IP Right Grant
- 1995-05-18 MX MX9701367A patent/MX9701367A/es not_active IP Right Cessation
- 1995-05-18 EP EP95917437A patent/EP0777649B1/en not_active Expired - Lifetime
- 1995-05-18 AU AU23506/95A patent/AU2350695A/en not_active Abandoned
- 1995-05-18 AT AT95917437T patent/ATE182138T1/de not_active IP Right Cessation
- 1995-05-18 ES ES95917437T patent/ES2133767T3/es not_active Expired - Lifetime
- 1995-05-18 US US08/793,225 patent/US5837720A/en not_active Expired - Fee Related
- 1995-05-18 JP JP7529926A patent/JP2935899B2/ja not_active Expired - Fee Related
- 1995-08-17 IL IL11496995A patent/IL114969A0/xx unknown
- 1995-08-23 CO CO95037814A patent/CO4410322A1/es unknown
- 1995-08-23 BR BR9503775A patent/BR9503775A/pt not_active IP Right Cessation
- 1995-08-24 TR TR95/01055A patent/TR199501055A2/xx unknown
-
1997
- 1997-02-21 FI FI970746A patent/FI116056B/fi not_active IP Right Cessation
-
1999
- 1999-09-01 GR GR990402218T patent/GR3031133T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| FI116056B (fi) | 2005-09-15 |
| MX9701367A (es) | 1997-05-31 |
| EP0777649B1 (en) | 1999-07-14 |
| WO1996006077A1 (en) | 1996-02-29 |
| US5837720A (en) | 1998-11-17 |
| FI970746A (fi) | 1997-02-21 |
| WO1996006078A1 (en) | 1996-02-29 |
| AU2350695A (en) | 1996-03-14 |
| CA2196885A1 (en) | 1996-02-29 |
| TR199501055A2 (tr) | 1996-07-21 |
| CA2196885C (en) | 2001-01-23 |
| DK0777649T3 (da) | 1999-11-29 |
| IL114969A0 (en) | 1995-12-08 |
| DE69510802T2 (de) | 1999-11-04 |
| FI970746A0 (fi) | 1997-02-21 |
| JP2935899B2 (ja) | 1999-08-16 |
| ATE182138T1 (de) | 1999-07-15 |
| EP0777649A1 (en) | 1997-06-11 |
| JPH09510731A (ja) | 1997-10-28 |
| DE69510802D1 (de) | 1999-08-19 |
| ES2133767T3 (es) | 1999-09-16 |
| GR3031133T3 (en) | 1999-12-31 |
| CO4410322A1 (es) | 1997-01-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2002531505A5 (pt) | ||
| ES2160949T3 (es) | Derivados de fenilen-sulfonamida sustituidos en meta. | |
| HUP0100870A2 (hu) | Analgetikumokként alkalmazható alfa-amino-amid-származékok | |
| RU94044436A (ru) | Способы подавления атрофии кожи и влагалища | |
| BR9503775A (pt) | Compostos e composição farmacêutica útil como um agente analgésico antiinflamatório diurético ou neuroprotetor | |
| JO2239B1 (en) | Method for preparing benzothophen derivatives | |
| YU2603A (sh) | Nova kombinacija (5ht2) agonista i (5ht6) antagonista serotonina kao farmaceutska kombinacija | |
| BR0108816A (pt) | Derivados de quinolina como antagonistas alfa-2 | |
| SE9900961D0 (sv) | Novel compounds | |
| IL137266A0 (en) | Heterocyclic chemokine receptor antagonists and pharmaceutical compositions containing the same | |
| CA2270955A1 (en) | Pharmaceutical composition containing morphinan derivative for treating drug dependence | |
| RU94044489A (ru) | Применение 2-фенил-3-ароилбензотиофенов для ингибирования миелопероксидазной активности | |
| RU2002130247A (ru) | Производные оксадиазола, обладающие противоопухолевым действием | |
| RU94045271A (ru) | Применение 2-фенил-3-ароилбензотиофенов для ингибирования синдрома тернера | |
| HUP0300298A2 (hu) | 4-[Piperazinil-8-(kinolinil-metil)]benzamid-származékok, alkalmazásuk és ezeket tartalmazó gyógyszerkészítmények | |
| GEP20043227B (en) | 5HT1 Antagonists for Antidepressant Therapy | |
| KR960037655A (ko) | 알츠하이머병 치료용 약제 | |
| CA2382654A1 (en) | Novel a-500359 derivatives | |
| KR970706819A (ko) | 브라디키닌 관련 증상 억제 방법(Method of Inhibiting Conditions Associated with Bradykinin) | |
| ATE248163T1 (de) | Neuartige, pharmazeutisch aktive verbindung | |
| WO2001007029A3 (en) | Substituted guanidines and the use thereof | |
| RU99118510A (ru) | Композиция для лечения или предупреждения рака простаты | |
| EA200401617A1 (ru) | Комбинация nmda-антагониста и ингибиторов ацетилхолинэстеразы для лечения болезни альцгеймера | |
| SE9302334D0 (sv) | New compounds | |
| EP0679396A1 (en) | Use of 3-substituted-2-oxidole-1-carboxamides for the manufacture of a medicament in the treatment and prevention of ischemia induced myocardial injury and cytokine mediated myocardial injury |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 3A, 4A, 5A, 6A, 7A, 8A, 9A, 10A, 11A, 12A, 13A, 14A, 15A, 16A E 17A ANUIDADES. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO PUBLICADO NA RPI 2162 12/06/2012. |